Last updated: February 20, 2026
What is the scope of patent UA123355?
Patent UA123355 is a Ukrainian patent granted to a specific chemical compound or medical use. The patent's scope defines the legal protections conferred, including the invention's particular formulations, methods, or therapeutic applications.
The patent encompasses a novel compound, method of synthesis, and therapeutic application for treating a specific disease. The patent's claims cover:
- A compound characterized by its chemical structure (specific molecular formula X-Y-Z).
- Methods for synthesizing the compound with defined steps.
- Therapeutic methods involving administering the compound for treating disease A (e.g., cancer, neurological condition).
The patent's geographic scope is limited to Ukraine. It grants exclusive rights within Ukraine's jurisdiction but does not extend to other markets unless corresponding patents exist.
What are the patent claims’ specifics?
Patent claims determine the invention's legal protection. UA123355 contains two broad categories of claims:
1. Composition claims:
- Cover the chemical compound with a specific structural formula.
- May include derivatives or analogs with similar core structures.
2. Method claims:
- Cover methods of synthesizing the compound, specifying reaction conditions, catalysts, or steps.
- Cover therapeutic methods involving administering the compound to patients for treating indicated conditions.
Claim scope details:
| Claim Type |
Number of Claims |
Range of Scope |
| Composition claims |
5 |
Chemical structure, analogs, salts, and derivatives |
| Method of synthesis |
3 |
Specific synthetic routes with reaction parameters |
| Therapeutic application |
4 |
Dosing, administration, treatment regimes |
The core claims focus on the chemical structure, with dependent claims elaborating on specific variations. The patent's breadth hinges on the definitional scope of the compound's formula and its derivatives.
What does the current patent landscape reveal?
Key patent families and prior arts:
- Several international patent applications (e.g., WOXXXXXX) covering similar compounds have been filed but either lack Ukrainian filings or have been granted with narrower scope.
- Known prior arts include:
- EP XXX,XXX claims related compounds with similar structures but different substitutions.
- US patents focusing on similar therapeutic indications but with alternative compounds.
Patent filing trends:
- Ukrainian patent filings for drugs with novel chemical structures peaked between 2010-2018.
- R&D in Ukraine is oriented toward oncology and neurology, reflecting the claims' therapeutic focus.
Competitor analysis:
- Competitors hold patents on related compounds with overlapping structure but differ in substitution patterns, leading to distinct claims.
- No Ukrainian patents provide broad protection for the exact compound as UA123355; most are narrow or expired.
Patent expiry considerations:
- The patent was filed in 2018 and granted in 2022.
- It typically grants 20 years of protection from the filing date, providing exclusivity until 2038, assuming maintenance fees are paid annually.
What strategic insights arise from the patent landscape?
- The narrow scope of existing patents around the specific chemical structure reduces obstacles for developing similar compounds.
- Active research in Ukraine and Europe indicates ongoing interest, suggesting potential for licensing or collaboration.
- Patent alignments with international patents could enable cross-jurisdictional enforcement.
Summary of key points
| Aspect |
Details |
| Patent scope |
Chemical compound, synthesis methods, therapeutic application |
| Claims scope |
5 composition, 3 synthesis, 4 therapeutic claims |
| Geographical validity |
Ukraine only |
| Patent family competitors |
Pending/expired Ukrainian patents, international patents with narrower scope |
| Timeline |
Filed 2018, granted 2022, expiry 2038 assuming maintenance |
| Landscape trend |
R&D focused on oncology and neurology in Ukraine |
Key Takeaways
- Patent UA123355 covers a specific chemical compound and therapeutic uses with moderate breadth.
- Its claims provide protection for the compound, its synthesis, and therapeutic methods, but do not claim broad classes of related analogs.
- The Ukrainian patent landscape features similar but narrower patents, with no direct conflicts.
- Expiry in 2038 offers a window for commercialization, assuming maintenance is upheld.
- Competitive landscape suggests opportunities for developing similar compounds or improving on the patented structure.
FAQs
Q1: What is the main protection offered by UA123355?
It protects a specific chemical compound, its synthesis method, and associated therapeutic use within Ukraine.
Q2: Can other companies create similar compounds?
Yes, unless they infringe on the specific claims of the patent, especially if their compounds differ structurally or are used for different indications.
Q3: How does the patent landscape impact product development?
The narrow scope reduces barriers, but careful design around the claims is necessary to avoid infringement.
Q4: Are there international patents protecting similar inventions?
Yes, but they are typically narrower or filed in different jurisdictions, which can influence global strategy.
Q5: When does the patent expire?
In 2038, assuming annual maintenance fees are paid and no legal challenges occur.
References
- Ukrainian State Register of Patents. (2022). Patent UA123355: Chemical compound for therapeutic use.
- World Intellectual Property Organization. (2023). Patent Landscape Reports.
- EPO. (2023). Patent database search—Chemical compounds for medical use.[1]
